ISL & Brainchip, page-8

That's a great find. How on earth did you manage to connect the dots on this and find that reference?

For transparency sake, I'm a long time lurker first time poster. Have just bought in again to BRN (after some very minor dabbling a few years ago) and am enjoying the commentary. Well, most of it anyway.

To my mind it seems like the only real issue at present is the transition from multiple partnerships and research/test engagements to revenue streams. NDAs apparently stifle the ability to keep shareholders across the opportunities and we just need to keep watching the 4C to see when revenues start to gather momentum.

Has there been any recent commentary from management as to when shareholders can expect to see revenue tick up or are we realistically still a couple of years away?

I'm asking in good faith here, not stirring the pot. As a long term WBT holder I do understand and acknowledge that getting to revenue is a long haul.

Anyway, excited to be back in BRN again and to watch further progress / updates unfold.